{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-0", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 0, "text": "Pexidartinib: MedlinePlus Drug Information\nwebsite belongs to an official government organization in the United States.\n(\nLock\nmeans you've safely connected to the .gov website. Share sensitive information only on official, secure websites.\n→\n→\nPexidartinib\nPexidartinib\npronounced as (pex\" I dar' ti nib)\nWhy is this medication prescribed?\nHow should this medicine be used?\nOther uses for this medicine\nWhat special precautions should I follow?\nWhat special dietary instructions should I follow?\nWhat should I do if I forget a dose?\nWhat side effects can this medication cause?\nWhat should I know about storage and disposal of this medication?\nIn case of emergency/overdose\nWhat other information should I know?\nBrand names\nIMPORTANT WARNING:\nPexidartinib may cause serious or life-threatening liver damage. Tell your doctor if you have or ever have had liver disease. Tell your doctor and pharmacist about the medications you are taking so they can check whether any of your medications may increase the risk that you will develop liver damage during your treatment with pexidartinib."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-1", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 1, "text": "and pharmacist about the medications you are taking so they can check whether any of your medications may increase the risk that you will develop liver damage during your treatment with pexidartinib. Call your doctor immediately if you experience any of the following: extreme tiredness, loss of appetite, weight loss, nausea, vomiting, unusual bleeding or bruising, rash, itching, fever, yellowing of the skin or eyes, dark yellow or brown-colored urine, pale stools, or pain in the upper right part of the stomach. Your doctor may have to decrease your dose or interrupt or stop your treatment.\nA program called Turalio Risk Evaluation and Mitigation Strategy (REMS) has been set up to manage the risks of this medication. You will only be able to receive pexidartinib if you and the doctor who prescribes your medication is enrolled are the program. You can only receive the medication from a pharmacy that participates in the program. Ask your doctor if you have any questions about participating in the program or how to get your medication.\nKeep all appointments with your doctor and the laboratory."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-2", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 2, "text": "hat participates in the program. Ask your doctor if you have any questions about participating in the program or how to get your medication.\nKeep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests before and during your treatment to be sure that it is safe for you to take pexidartinib and to check your body's response to the medication.\nYour doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with pexidartinib and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (\nhttps://www.fda.gov/Drugs/DrugSafety/ucm085729.htm\n) or the manufacturer's website to obtain the Medication Guide.\nTalk to your doctor about the risks of taking pexidartinib.\nWhy is this medication prescribed?\nPexidartinib is used to treat a certain type of tenosynovial giant cell tumors (TGCT; tumors in or around a joint that can cause pain, swelling, and reduce movement). Pexidartinib is in a class of medications called kinase inhibitors."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-3", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 3, "text": "tain type of tenosynovial giant cell tumors (TGCT; tumors in or around a joint that can cause pain, swelling, and reduce movement). Pexidartinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that may help the tumor to shrink.\nHow should this medicine be used?\nPexidartinib comes as a capsule to take by mouth. It is usually taken two times a day with a low-fat meal or snack (about 400 calories, 11-14 grams fat). Ask your doctor for examples of foods that contain 11-14 grams of fat that you can eat when you take pexidartinib. Taking pexidartinib with a high-fat meal (about 800-1000 calories, 55-65 grams fat) may cause side effects. Do not take pexidartinib without food. Take pexidartinib at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take pexidartinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.\nSwallow the capsules whole; do not open, chew, or crush them.\nIf you vomit after taking pexidartinib, do not take another dose."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-4", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 4, "text": "ore or less of it or take it more often than prescribed by your doctor.\nSwallow the capsules whole; do not open, chew, or crush them.\nIf you vomit after taking pexidartinib, do not take another dose. Continue your regular dosing schedule.\nYour doctor may decrease your dose  or interrupt or  stop your treatment. This depends on how well the medication works for you and the side effects you experience. Be sure to tell your doctor how you are feeling during your treatment with pexidartinib.\nOther uses for this medicine\nThis medication may be prescribed for other uses; ask your doctor or pharmacist for more information.\nWhat special precautions should I follow?\nBefore taking pexidartinib,\ntell your doctor and pharmacist if you are allergic to pexidartinib, any other medications, or any of the ingredients in pexidartinib capsules. Ask your pharmacist or check the Medication Guide for a list of the ingredients.\ntell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-5", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 5, "text": "ist of the ingredients.\ntell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.\nif you are taking antacids containing magnesium or aluminum (Maalox\n®\n, Mylanta\n®\n, Tums\n®\n, others), take the antacid 2 hours before or at least 2 hours after you take pexidartinib.\nif you are taking a medication for indigestion, heartburn, or ulcers such as cimetidine, famotidine, nizatidine, or ranitidine, take it at least 10 hours before or at least 2 hours after you take pexidartinib.\nthe following nonprescription or herbal products may interact with pexidartinib:  esomeprazole, lansoprazole, omeprazole, and St. John's wort. Be sure to let your doctor and pharmacist know that you are taking these medications before you start taking pexidartinib."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-6", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 6, "text": "pexidartinib:  esomeprazole, lansoprazole, omeprazole, and St. John's wort. Be sure to let your doctor and pharmacist know that you are taking these medications before you start taking pexidartinib. Do not start any of these medications while taking pexidartinib without discussing you're your healthcare provider.\nyou should know that pexidartinib may decrease the effectiveness of hormonal contraceptives (birth control pills, patches, rings, and injections). You will need to use another method of contraception to prevent pregnancy while taking pexidartinib. Talk to your doctor about other ways to prevent pregnancy while you are taking this medication.\ntell your doctor if you have or have ever had high cholesterol, high blood pressure, or  kidney disease.\ntell your doctor if you are pregnant, plan to become pregnant, or if you plan to father a child. If you can become pregnant, you will need to take a pregnancy test before you start treatment and use non-hormonal birth control to prevent pregnancy during your treatment and for 1 month after your final dose."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-7", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 7, "text": "become pregnant, you will need to take a pregnancy test before you start treatment and use non-hormonal birth control to prevent pregnancy during your treatment and for 1 month after your final dose.   If your partner can become pregnant, you should use birth control during your treatment and for 1 week after your final dose. Talk to your doctor about birth control methods that you can use during your treatment. If you or your partner become pregnant while taking pexidartinib, call your doctor immediately. Pexidartinib may harm the fetus.\ntell your doctor if you are breastfeeding. You should not breastfeed while you are taking pexidartinib and for 1 week after your final dose.\nyou should know that this medication may decrease fertility in men and women. Talk to your doctor about the risks of taking pexidartinib.\nplan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-8", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 8, "text": "y in men and women. Talk to your doctor about the risks of taking pexidartinib.\nplan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen. Pexidartinib may make your skin sensitive to sunlight.\nWhat special dietary instructions should I follow?\nDo not eat grapefruit or drink grapefruit juice while taking this medication.\nWhat should I do if I forget a dose?\nSkip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.\nWhat side effects can this medication cause?\nPexidartinib may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:\nhair color changes\nchanges in taste\ntiredness or weakness\nconstipation\nhives, red skin, acne\nswelling of the hands, feet, legs or ankles\nswelling in or around the eye\nnumbness, burning, or tingling in the arms, hands, feet, or leg\nPexidartinib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-9", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 9, "text": "ound the eye\nnumbness, burning, or tingling in the arms, hands, feet, or leg\nPexidartinib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication. If you experience any of the symptoms listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment\nWhat should I know about storage and disposal of this medication?\nKeep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Do not remove the desiccant (small packet included with medication to absorb moisture) from the bottle, if one has been provided.\nKeep all medication out of sight and reach of children as many containers are not child-resistant. Always lock safety caps. Place the medication in a safe location - one that is up and away and out of their sight and reach.\nhttps://www.upandaway.org\nDispose of unneeded medications in a way so that pets, children, and other people cannot take them. Do not flush this medication down the toilet. Use a medicine take-back program."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-10", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 10, "text": "//www.upandaway.org\nDispose of unneeded medications in a way so that pets, children, and other people cannot take them. Do not flush this medication down the toilet. Use a medicine take-back program. Talk to your pharmacist about take-back programs in your community. Visit the FDA's Safe Disposal of Medicines website\nhttps://goo.gl/c4Rm4p\nfor more information.\nIn case of emergency/overdose\nIn case of overdose, call the poison control helpline at\n1-800-222-1222\n. Information is also available online at\nhttps://www.poisonhelp.org/help\n. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.\nWhat other information should I know?\nDo not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.\nKeep a written list of all of the prescription and nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking. Bring this list with you each time you visit a doctor or if you are admitted to the hospital."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050-11", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a619050.txt", "chunk_index": 11, "text": "nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking. Bring this list with you each time you visit a doctor or if you are admitted to the hospital. You should carry the list with you in case of emergencies.\nBrand names\nTuralio\n®\nLast Revised -\n12/15/2022"}
